Migraine. Migraine
Conditions
Interventions
Intervention 1: Intervention group: 25 Migraine patients follow a three-month anti-inflammatory diet(includes daily intake of fruits and fresh vegetables (raw or cooked in various colors), whole grain
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Willingness to cooperate with the plan Diagnosis of migraine by a neurologist based on ICHD-3 criteria. Age 20 to 50 years. No chronic diseases (liver, kidney, cardiovascular disease, secondary headache or other types of primary headache except migraine) Absence during pregnancy and lactation .. Taking dietary supplements or medication (nutritional supplements, multivitamin mineral and W3 supplements or anti-migraine medications (valproate, amitriptyline, etc.), anti-inflammatory and anti-depressant pills, Aspirin and NSAIDs, contraceptives in the last three months Failure to follow a specific diet or exercise program during the last three months No alcohol and smoking
Exclusion criteria
Exclusion criteria: Failure to follow the recommendations and diet. Failure to refer the person at different stages of the study. Cardiovascular disease, hypertension, diabetes, liver, kidney, thyroid, malignancies and other neurological disorders. Taking nutritional and herbal supplements that affect migraines including riboflavin, feverfew, magnesium and coenzyme Q10
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of migraine. Timepoint: At the beginning of the study (before the intervention) and three months after the start of adherence to die. Method of measurement: Visual Analogue Scale.;Migraine frequency. Timepoint: At the beginning of the study (before the intervention) and three months after the start of adherence to die. Method of measurement: Question / Number of attacks per month.;Duration of migraine headache. Timepoint: At the beginning of the study (before the intervention) and three months after the start of adherence to die. Method of measurement: Question / Average duration of each migraine attack.;The degree of disability caused by migraines. Timepoint: At the beginning of the study (before the intervention) and three months after the start of adherence to die. Method of measurement: Headache Impact Test Questionnaire.;IL-6. Timepoint: At the beginning of the study (before the intervention) and three months after the start of adherence to die. Method of measurement: Kit Eliza. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSiavash fazelian
Shahre-kord University of Medical Sciences
Outcome results
None listed